The document discusses the need for pharmaceutical, biotech, medical device, and cosmetics companies to streamline regulatory procedures through automation and integration of regulatory software. It emphasizes the importance of balancing automation with a focus on drug innovation and suggests selecting proven regulatory tools. Freyr offers various regulatory tools to meet market demands and streamline data collection for timely submissions and approvals.